Study Highlights Opioid Prescription Rates Among Idaho Women of Reproductive Age: What It Means For Our State

Why it matters locally: This national study highlighting high opioid prescription rates among women of reproductive age (15-44) directly impacts Idaho due to its potential implications for maternal and infant health, as well as the broader opioid crisis already affecting the state. With a population of nearly 2 million, a significant portion of which are women in this age group, any trend towards increased opioid use in Idaho can lead to increased rates of Neonatal Abstinence Syndrome (NAS) among newborns, strained healthcare resources, and increased costs for both Medicaid, which is a significant player in Idaho healthcare, and private insurance companies. Furthermore, higher opioid prescription rates in this demographic can contribute to long-term addiction issues and family challenges, adding to the existing social and economic burdens related to opioid abuse in Idaho.

---

A report in the Morbidity and Mortality Weekly Report (MMWR) has examined the prevalence of opioid painkiller prescriptions among women of reproductive age in the United States between 2008 and 2012. The Centers for Disease Control and Prevention (CDC) released the report. The study focused on women aged 15-44 who were enrolled in either Medicaid or had private insurance. Researchers analyzed prescription data to determine the percentage of women filling at least one opioid prescription each year during the five-year period. The findings indicated that a significant portion of women in this demographic received opioid prescriptions. The report stated that over one-third of reproductive-aged women enrolled in Medicaid filled an opioid painkiller prescription annually. Among women with private insurance, the rate was over one-quarter. The report does not offer reasons for the prescription rates, but it provides a quantification of opioid use among women during their reproductive years. Further research would need to be done to determine the conditions for which the opioids were prescribed, the dosages prescribed, and the long-term outcomes for the respective patients. The scope of the study was limited to the period from 2008 to 2012. Data on more recent trends in opioid prescriptions for this population would provide a more current understanding of the issue.